Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Cholangiocarcinoma (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Gallbladder Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 1)
Gliosarcoma (Phase 1)
Hamartoma (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Prostatic Neoplasms, Castration-Resistant (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue